Elizabeth McKenna: The inaugural Cancer Discovery Early Career Award nominations
Elizabeth McKenna, shared a post by , on LinkedIn, adding:
“Applicants must be the first or corresponding author of an article published in Cancer Discovery in 2022 or 2023.
Applicants must hold an appointment as Assistant Professor or equivalent, and their Cancer Discovery article must be published within 12 years of receiving their PhD/MD.
Please apply/share with eligible colleagues!”
Quoting ‘s post:
“We are excited to announce the inaugural Cancer Discovery Early Career Award. Early-career scientists and senior scientists with early-career colleagues are encouraged to nominate those who meet the Award criteria. Nominations are open until January 5.”
For details click here.
Source: Elizabeth McKenna/LinkedIn and
Elizabeth McKenna is the Executive Director of Cancer Discovery at the American Association for Cancer Research. Elizabeth earned her PhD from Harvard University and trained with Dr. Charles Roberts at the Dana-Farber Cancer Institute. Her research was among the first to show that pediatric tumors characterized by mutations in chromatin remodelers are genomically stable and instead driven by epigenetic deregulation of key target genes. She joined Cancer Discovery shortly after its launch as its founding Science Writer and became an editor in 2014, rising through the editorial ranks to become the journal’s Executive Editor in 2019. She is a member of the 40 Under 40 in Cancer Class of 2021.